Detalhe da pesquisa
1.
Treatment of thrombotic cardiovascular diseases in people with haemophilia: A Japanese consensus study.
Haemophilia
; 2024 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38783547
2.
Association of patient, treatment and disease characteristics with patient-reported outcomes: Results of the ECHO Registry.
Haemophilia
; 30(1): 106-115, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38030962
3.
Haemophilia and cardiovascular disease in Japan: Low incidence rates from ADVANCE Japan baseline data.
Haemophilia
; 29(6): 1519-1528, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37806778
4.
The length of the sanitary napkins can be used as a handier index than pictorial blood loss assessment chart to predict the heavy menstrual bleeding.
J Obstet Gynaecol Res
; 49(7): 1838-1845, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37141923
5.
Long-term safety and efficacy of emicizumab for up to 5.8 years and patients' perceptions of symptoms and daily life: A phase 1/2 study in patients with severe haemophilia A.
Haemophilia
; 27(1): 81-89, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33236410
6.
Ischaemic events are rare, and the prevalence of hypertension is not high in Japanese adults with haemophilia: First multicentre study in Asia.
Haemophilia
; 25(4): e223-e230, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31045306
7.
[Successful long-term management of ovarian bleeding and menorrhagia with prothrombin complex concentrate in a patient with congenital factor X deficiency].
Rinsho Ketsueki
; 59(11): 2428-2431, 2018.
Artigo
em Japonês
| MEDLINE | ID: mdl-30531138
8.
Successful emicizumab prophylaxis during dual antiplatelet therapy for insertion of drug-eluting stents after acute coronary syndrome: A case report.
Haemophilia
; 27(4): e549-e550, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33780095
9.
Real-world long-term safety and effectiveness of turoctocog alfa in the treatment of haemophilia A in Japan: results from a multicentre, non-interventional, post-marketing study.
Hematology
; 29(1): 2316540, 2024 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38376107
10.
Noninterventional study assessing joint health in persons with hemophilia A after switching to turoctocog alfa pegol: design of pathfinderReal.
Res Pract Thromb Haemost
; 8(2): 102363, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38572481
11.
Association of physical activity with bleeding events and safety in patients with haemophilia A starting emicizumab prophylaxis: an interim analysis of the TSUBASA study.
Int J Hematol
; 119(1): 14-23, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38100026
12.
Real-World Use of Albutrepenonacog Alfa, A Recombinant Coagulation Factor IX Albumin Fusion Protein, for Personalized Prophylaxis in Japanese Individuals With Hemophilia B: A Case Series.
Cureus
; 15(1): e33573, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36779089
13.
Real-World Experience of People with Hemophilia A Receiving Turoctocog Alfa Pegol (N8-GP): Results from a Patient Experience Survey.
Patient Prefer Adherence
; 17: 3001-3014, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38027080
14.
Burden of congenital hemophilia A requiring treatment in Japan: The HIKOBOSHI study.
Res Pract Thromb Haemost
; 6(7): e12825, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36320425
15.
Turoctocog alfa pegol (N8-GP) in severe hemophilia A: Long-term safety and efficacy in previously treated patients of all ages in the pathfinder8 study.
Res Pract Thromb Haemost
; 6(2): e12674, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35308099
16.
AKATSUKI study: a prospective, multicentre, phase IV study evaluating the safety of emicizumab under and immediately after immune tolerance induction therapy in persons with congenital haemophilia A with factor VIII inhibitors.
BMJ Open
; 12(3): e057018, 2022 03 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35288393
17.
AOZORA: long-term safety and joint health in paediatric persons with haemophilia A without factor VIII inhibitors receiving emicizumab - protocol for a multicentre, open-label, phase IV clinical study.
BMJ Open
; 12(6): e059667, 2022 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35697445
18.
The seroprevalence of neutralizing antibodies against the adeno-associated virus capsids in Japanese hemophiliacs.
Mol Ther Methods Clin Dev
; 27: 404-414, 2022 Dec 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36381300
19.
Long-term safety and efficacy of rIX-FP prophylaxis with extended dosing intervals up to 21 days in adults/adolescents with hemophilia B.
J Thromb Haemost
; 18(5): 1065-1074, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32078256
20.
Development and Validation of a Population-Pharmacokinetic Model for Rurioctacog Alfa Pegol (Adynovate®): A Report on Behalf of the WAPPS-Hemo Investigators Ad Hoc Subgroup.
Clin Pharmacokinet
; 59(2): 245-256, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31435896